Dasatinib 66993-0238
Product NDC
66993-0238- Manufacturer
- Prasco Laboratories
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 3, 2024
- Listing Expires
- December 31, 2026
- Application
- NDA021986
Need to source Dasatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dasatinib | 140 mg/1 |
Drug Class
Cytochrome P450 3A4 Inhibitors [MoA]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(1)
1 BOTTLE in 1 CARTON (66993-238-30) / 30 TABLET in 1 BOTTLE